Introduction
Gene therapy is defined as the transfer of genetic material to achieve the therapeutic effect of tissue repair. 1 The focus of gene therapy is to place therapeutic agents at the injury site at safe levels, to avoid toxicity, but have a therapeutic effect. 1 While several different approaches have been used to transfer genes into cells and tissues, liposomal nonviral gene transfer represents a safe and efficacious method for gene transfer. 2 The broad application of liposomal gene transfer was limited by low transfection and expression rates. 3 However, in acute dermal and epidermal wounds liposomal gene transfer of genes coding for growth factors was shown to be effective in improving dermal and epidermal regeneration. [4] [5] [6] Therefore, we used the physiologic cascade of wound healing as a model to investigate the effect of nonviral liposomal gene transfer. Wound healing is a dynamic interactive and complex process involving soluble mediators, blood cells, extracellular matrix and parenchymal cells. 7 Different cell types synthesize and release different mediators that modulate and stimulate the cascade of wound healing. These mediators encompass multiple chemokines and growth factors. Particularly, growth factors have been suggested to influence and modulate epidermal and dermal regeneration. 7, 8 As dermal and epidermal regeneration has been shown to be crucial for survival of many pathophysiologic states, such as burns, an accelerated rate of wound healing would be beneficial. 9 Among many growth factors that may play a role during the wound healing cascade, few growth factors were delivered by liposomal gene transfer. Sun et al 6 used FGF, Nakamura et al 11 used PDGF and our group used insulin like-growth factor-I (IGF-I) and keratinocyte growth factor (KGF). 5, 10 All these growth factors when given individually were shown to improve wound healing, collagen or skin breaking strength, skin quality or dermal and epidermal regeneration. 5, 6, 10, 11 However, given the complexity and the many factors involved in the cascade, a mono-therapy may not be sufficient. Thus, we hypothesized that a gene transfer of two genes may be more effective than a mono-gene therapy. From previous experiments, we found that KGF, a 26-28 kDa protein, is an epithelial growth factor that exerts its effects mainly in a paracrine manner and is essential for skin morphogenesis. stimulate epithelial cell differentiation and it appears to control the proliferative-differentiative program from basal to suprabasal cells in the skin. 14 Moreover, KGF stimulates proliferation and exerts an antiapoptotic effect for epithelial cells, which are of major importance for the post-traumatic wound healing. [15] [16] [17] Another growth factor that was found to be effective in the wound healing process is IGF-I. IGF-I, a protein of 7.7 kDa, is a mesenchymal growth factor that accelerates wound healing by stimulating collagen synthesis and the mitogenicity of fibroblasts and keratinocytes. 16, 18 We have recently shown that exogenous IGF-I cDNA administration leads to an endogenous stimulation of the IGF-I gene, and dermal and epidermal regeneration is markedly improved in acute wounds. 18 In combining two growth factors, the purpose of the present study was to determine whether the combination of a mesenchymal (IGF-I) and epithelial growth factor (KGF) would have an additive effect on the physiological and biological response to enhance dermal and epidermal regeneration, and thus whether a gene transfer of multiple genes represents a possible clinical approach.
Results

Transfection
Confirming previous experiments, the fine granular blue-green reaction product of the b-galactosidase reaction was predominantly present in the granulation tissue underlying the wound. The cells consistently staining for b-galactosidase were myofibroblasts, endothelial cells, macrophages located in the areas of inflammation and multinucleate giant cells (Figure 1 ).
IGF-I and IGFBP-3 protein concentration
IGF-I protein concentration in the skin, determined by immunohistochemistry, showed that animals receiving the IGF-I cDNA construct and the IGF-I/KGF cDNA construct had significantly increased IGF-I protein concentrations when compared with controls, Po0.05. (Figure 2a ). By using antibodies against IGF-I, we detected IGF-I expression in the same area in which we found a positive reaction for transfection, indicated by the histological examinations for b-galactosidase. Rats receiving the IGF-I cDNA or the IGF-I/KGF cDNA construct had an increased number of positive cells per HPF and thus per mm 2 using antibodies against IGF-I when compared with controls, Po0.05 (Figure 2a) . Rats receiving the KGF cDNA alone also demonstrated an increase in IGF-I protein concentration when compared with liposomes, Po0.05 (Figure 2a) .
IGFBP-3 protein concentration was significantly increased in rats receiving the IGF-I cDNA, KGF cDNA and IGF-I/KGF cDNA when compared to control rats, Po0.001 (Figure 2b 
Physiologic response
Re-epithelization. Re-epithelization, determined by planimetry, was significantly increased in rats receiving the liposomal IGF-I/KGF cDNA complexes when compared with rats receiving the IGF-I cDNA, KGF cDNA or liposomes containing the cDNA for b-galactosidase, Po0.05. (Figure 3a ). The group with the cotransfection of IGF-I and KGF demonstrated a 250% accelerated reepithelization when compared to control, Po0.0001. Histological examinations of re-epithelization revealed similar results as planimetric measurements. Rats treated with the IGF-I/KGF cDNA gene complex demonstrated the most accelerated re-epithelization. At 5 weeks after the wound infliction in the IGF-I/KGF gene group, linear re-epithelization was 496745 mm, in the IGF-I cDNA group 380729 mm and in the KGF cDNA group 394717 mm, while re-epithelization was significantly less with 240719 mm in the control group, Po0.001 (Figure 3b ).
Epithelial cell layers.
No differences in epithelial cell layers could be found between the IGF-I (1572), KGF Collagen morphology and deposition. IGF-I/KGF cDNA gene transfer improved the quality and quantity of deposited collagen (Table 1 ). In rats receiving the IGF-I/KGF cDNA, collagen formation was significantly higher than the collagen formation in rats receiving vehicle. Furthermore, the staining intensity of collagen deposition was significantly higher in rats treated with IGF-I/KGF cDNA when compared with IGF-I, KGF or vehicle, Po0.05 (Table 1 ). We also found that IGF-I/KGF cDNA significantly increased the length of the collagen pannus and the area of the collagen pannus when compared to IGF-I cDNA, KGF cDNA and vehicle, Po0.05 (Table 1) .
Neoangiogenesis. IGF-I/KGF cDNA treatment increased the amount of blood vessels per HPF, and thus neoangiogenesis. The IGF-I/KGF cDNA-treated group had 1771.5 blood vessels per HPF (62 vessels per mm 
Discussion
Tissue repair and regeneration are the normal biological responses of many different tissues in the body to injury. 1 During the healing process profound changes occur intra-and extracellularly. Wound healing, being an example for tissue repair, is critical for morbidity and mortality in acute and chronic wounds. In the US alone, over 2 million people suffer from burns and approxi- 19 Many novel drugs and devices are being developed to modulate the rate of epidermal and dermal regeneration with the primary goal of rapid wound closure with functional and aesthetically good skin, one of which being chemokines and growth factors. Growth factors have been shown to influence epidermal and dermal regeneration. 8, 20 However, the clinical use of recombinant growth factors has not been as beneficial as once expected. This is not really surprising given the complexity and the variability of the interactions between cells, soluble cytokines, blood elements and extracellular matrix. Further, clinicians did not take into account the question of which delivery system could be effectively used for growth factors. In chronic wounds, growth factors are decreased due to proteases. 21 More important is that the receptors for the growth factors are also decreased. Thus, application of recombinant human growth factors as proteins cannot be effective, because there are no receptors that the growth factors can bind to initiate the signal cascade. New therapeutic strategies are needed to improve the efficacy of growth factor application and consecutive epidermal and dermal regeneration, one of which being the use of liposomal cDNA gene complexes.
Liposomal cDNA gene transfer represents a unique therapeutic approach for several pathophysiologic states and tissue repair and regeneration. [2] [3] [4] Cationic lipids and liposomes are easy to prepare, use, apply and sterilize. 2 Liposomes are stable and do not cause immunologic reactions. 2 Others and we have shown that nonviral liposomal gene transfer is useful for the treatment of skin diseases. 5, 6 Liposomes can be applied by either topical administration or by direct injection of liposomal gene constructs. [4] [5] [6] Alexander et al demonstrated that topical application of liposomal constructs containing the Lac Zgene in shaved 4-week-old mice resulted in a transfection and expression in the epidermis, dermis and hair follicle. 4 Topical administration of liposomal complexes, however, has been speculated not to be as effective as injection in cell transfection and expression. 3, 4 This is due to the stratum corneum, which is the protective layer of the epidermis. Thus, injecting the liposomal gene complexes improves transfection of dermal and epidermal cells. After normal skin transfection, expression is predominantly in keratinocytes with lower levels of expression in dermal cells. 3 Transfection, however, has been shown to be transient under these conditions. [3] [4] [5] The reason for transient transfection and expression is due to degradation and loss of the DNA constructs and a lack of stable gene transfection into stem cells, for example, keratinocyte stem cells. 3 The present study investigated whether the administration of multiple cDNAs is more effective and therefore represents a new effective therapeutic option. We showed that transfer of multiple genes, KGF and IGF-I cDNA had additive effects when compared to the administration of the same growth factors individually. In preliminary studies, we found that exogenous IGF-I cDNA liposomal gene transfer results in increased IGF-I mRNA and local IGF-I protein concentrations, with a concomitant change of IGFBP-1 and IGFBP-3. 18 These findings indicate that exogenous IGF-I cDNA gene transfer causes similar cellular and physiologic responses as endogenous IGF-I, which leads us to hypothesize that the exogenous transferred gene is recognized by the cell and initiates the same molecular cascade. This is probably the reason why IGF-I cDNA gene transfer is safe and efficacious in improving dermal and epidermal regeneration, by accelerating re-epithelization and wound healing. In further studies we showed that the administration of the IGF-I cDNA gene is not the only positive growth factor that results in better wound healing. KGF cDNA transfer also led to better and faster wound healing in acute wounds. 11 KGF is synthesized by several mesenchymal cells, such as fibroblasts, 12, 15 For KGF to exert its effects, which is mainly in a paracrine manner, KGF needs to bind to its receptor FGFR2-IIIb, which is expressed in keratinocytes and hair follicles. 13, [22] [23] [24] Activating the KGF receptor leads, through phosphorylation, to proliferation of epithelial cells and is responsible for the morphogenesis of the skin and thus plays an important role during wound healing. 12 After wounding, KGF protein and mRNA concentration increases and they are mainly present in the dermal fibroblasts below the wound and at the wound edges, whereas KGF receptor transcripts and also the corresponding protein were exclusively detected in keratinocytes of the epidermis and the hair follicles. 17 These cells migrate over the wound and subsequently proliferate, which leads to complete wound re-epithelization. Conforming to previous experiments, we showed in the present study that the gene transfer of IGF-I cDNA and KGF cDNA individually demonstrated the same effects as previously shown.
In the present study, we showed that IGF-I and KGF administered as a combination of both cDNAs had positive effects on dermal and epidermal regeneration in accelerating re-epithelization, increasing skin cell balance in increasing proliferation and deceasing skin cell apoptosis when compared to controls, IGF-I and KGF given alone. In addition, gene transfer of multiple genes led to improved quality of the dermal and epidermal structures. Most striking was the accelerated re-epithelization. While rats receiving liposomes with the Lac Z gene had a re-epithelization of 18% after 5 weeks, rats receiving liposomes with the KGF and the IGF-I gene demonstrated a re-epithelization rate of 40% of the original wound, which is an increase of 225%. Translated into the clinics of a burn wound, a patient receiving liposomes plus Lac Z has one leg healed after 40 days, while a patient receiving liposomes plus IGF-I and KGF has two legs healed and part of his abdomen. In the burn model, the wound is the major source of proinflammatory mediators such as cytokines and proinflammatory hormones. 9 Proinflammatory mediators lead to hypermetabolism and catabolism, which in turn is associated with increased mortality and morbidity. 25 Thus, accelerated wound healing results in better outcome and survival of burned patients. Based on our data, we hypothesize that not only would a burn patient benefit from an accelerated wound healing but also other pathophysiologic states would benefit from better and faster tissue regeneration.
Vascular supply of the wound is essential for wound healing and reliant on neovascularization. During wound healing, angiogenic capillary sprouts invade the fibrin/fibronectin-rich wound and within a few days organize into a microvascular network in the granulation tissue. 26 Neovascularization depends on a dynamic interaction between endothelial cells, cytokines and the extracellular matrix. 27 Vascular endothelial growth factor (VEGF) stimulates and increases neovascularization. 27 Chronic wounds, or impaired wound have decreased concentrations of VEGF and fewer blood vessel in the granulation tissue when compared with physiologic wounds, which is probably due to increased proteolysis of VEGF. 28 We found that IGF-I, KGF and the combination of IGF-I/KGF cDNA transfer increased the number of newly formed blood vessels in the granulation tissue.
Supporting this finding is the increased concentration of VEGF, which we showed by immunohistochemical staining with antibodies against VEGF. Multiple cDNA transfer increased VEGF concentration in the wound, which in turn leads to increased neoangiogenesis.
The skin is a good model to study the mechanisms mediating nonviral gene transfer because of its accessibility and the ease of monitoring the modified area and it is likely that the mechanisms are found in other organs and modes of application as well. 4 In the present study, we demonstrated some new mechanistic insights after nonviral liposomal gene transfer. We showed that the administration of a combination with multiple cDNA genes had additive physiologic effects during a pathophysiologic state. We used a wound model and found that the gene transfer of IGF-I plus KGF cDNA exerted positive effects on dermal and epidermal regeneration in accelerating re-epithelization, improving skin cell balance and the quality of the dermal and epidermal structures. Based on these findings, we conclude that a combination of multiple genes is possible and can be more effective than a mono-therapy. This opens up new therapeutic options as now a combination of different factors can be administered to improve tissue or organ regeneration of different pathophysiologic states.
Material and methods
In total, 40 adult male Sprague-Dawley rats (350-375 g) were placed in wire-bottom cages housed in a temperature-controlled room with a 12-h light-dark cycle. Rats were acclimatized to their environment for 7 days before the blinded study. All animals received similar amounts of a liquid diet of Fresubin (Fresenius Medical Care, Germany) and water ad libitum throughout the study. Each rat received a 30% total body surface area (TBSA) full-thickness scald burn under general anesthesia (Pentobarbital 50 mg/kg body weight) and analgesia (Buprenorphin 1 mg/kg body weight) following a modified procedure as previously described. 29 Rats were anesthetized, shaved and placed in a mole and received a 30% TBSA scald burn (991C hot water contact 10 s to the back). After the thermal injury, rats were immediately resuscitated by intraperitoneal injection of Ringer's Lactate (50 ml/kg body weight). Thermally injured rats were then randomly divided into one of the four groups: 
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In previous experiments, we found that animals receiving liposomes containing the Lac-Z gene represented a better control compared to animals receiving saline, in having better wound healing rates and an attenuated acute phase response. Therefore, we chose in the present study to use liposomes with Lac-Z as the control group. The rat IGF-I and KGF cDNA constructs consisted of a CMV-driven IGF-I or KGF cDNA plasmid prepared at the UTMB Sealy Center for Molecular Science Recombinant DNA Core Facility. The liposomes were formulated from 1:1 (M/M) DMRIE (1,2-dimyristyloxypropyl-3-dimethyl-hydroxyl ethyl ammonium bromide) and cholesterol suspended in membrane-filtered water (Life Technologies, Rockville, MD, USA). This reagent interacts spontaneously with IGF-I cDNA to form the lipid cDNA complex. The dose of 2.2 mg for the IGF-I cDNA, the KGF cDNA and the cotransfection of IGF-I/KGF cDNA was defined in a dose response study.
Immediately after the thermal injury, each rat received 0.2 ml of the lipoplexes subcutaneously injected at two sites opposite from each other. This was repeated each week for 4 weeks. Mixtures were prepared fresh before injections. Animals were humanely killed by decapitation 5 days after the last injection. Skin samples from the back were harvested, fixated in 4% paraformaldehyde, 1% glutaraldehyde, or snap-frozen in liquid nitrogen and stored at À73 o C for analysis.
Transfection
Transfection was determined in skin samples taken 33 days after burn and 5 days after the last injection by measuring the presence of b-galactosidase. The presence of the b-galactosidase protein was detected by histochemical staining with Bluo-Gal (halogenated indolyl-b-D-galactoside) (LIFE Technologies, Gaithersburg, MD, USA) for b-galactosidase in the skin. Linear skin biopsies approximately 4 mm thick in width and extended from the center of the burn wound well into surrounding normal skin were taken at the end of the experiment and processed as previously published. 18 
IGF-I and IGFBP-3 protein concentration
IGF-I protein concentrations in dermal and epidermal tissues were measured using antibodies against IGF-I with standard immunohistochemical techniques. Paraffin-embedded samples were cut 4 mm in thickness, placed in increasing alcohol concentrations and finally in phosphate-buffered saline (PBS). Protease K (100 mg/ ml) was applied at 371 for 30 min. After washing with PBS, endogen peroxidases were blocked using methanol-H 2 O 2 for 15 min. The samples were then washed again. Samples were incubated with pig serum (1:5, DAKO X901) for 20 min. After washing, the primary antibody rabbit anti-IGF-I (1:10, Peprotech, TEBU Germany) was applied to the samples and then incubated at 41C twice overnight. After another washing, the secondary antibody DAKO E 431 (biotinylated swine antirabbit, 1:300) was incubated for 1 h at 371C followed by another washing. The samples were then incubated with Streptavidin (1:300; DAKO P 0397) for 1 h at 371C. The samples were thoroughly washed and diaminobenzidine-hydrogen peroxidase was applied for color development. The counterstaining was performed using hematoxylin. After placing the samples in increasing alcohol concentrations, they were mounted. IGF-I concentration was determined by the number of positive cells per HPF and per mm 2 . Three observers blinded for treatment counted each sample at three different sites for IGF-I-positive cells.
IGFBP-3 concentrations were determined using antibodies against IGFBP-3 with standard immunohistochemical techniques as described in the paragraph above. The antibody used was a goat anti-IGFBP-3 (Santa Cruz-Biotechnology, 1:10).
KGF and VEGF protein concentration
KGF protein concentrations in the skin were measured by antibodies against KGF using standard immunohistochemical techniques. Paraffin-embedded samples were cut 4 mm in thickness, placed in an increasing alcohol concentration and finally in PBS. Protease K (100 mg/ml) was applied at 371 for 30 min. After washing with PBS, endogen peroxidases were blocked using methanol-H 2 O 2 for 15 min. The samples were then washed again. The primary antibody goat anti-KGF (Santa Cruz Biotechnology) was applied to the samples and then incubated at 41C overnight. After another washing, the secondary antibody DAKO E 0466 (biotinylated rabbit anti-goat, 1:400) was incubated for 1 h at 371C followed by another washing. The samples were then incubated with Streptavidin (1:300; DAKO P 0397) for 1 h at 371C. The samples were thoroughly washed and diaminobenzidine-hydrogen peroxidase was applied for color development. The counterstaining was performed using hematoxylin. After placing the samples in an increasing alcohol, they were mounted. KGF concentration was determined by the number of positive cells per HPF and per mm 2 . Three observers blinded for treatment counted each sample at three different sites for KGF-positive cells.
VEGF protein concentrations in the skin were measured by antibodies against VEGF using standard immunohistochemical techniques. Paraffin-embedded samples were cut 4 mm in thickness, placed in an increasing alcohol concentration and finally in PBS. Pretreatment was carried out in a microwave for 30 min at 240 W. After washing with PBS, endogen peroxidases were blocked using methanol-H 2 O 2 for 15 min. The samples were then washed again. The primary antibody rabbit anti-VEGF (PC 315, Oncogene Research Products, 1:50) was applied to the samples and then incubated at 41C overnight. After another washing, the secondary antibody (DAKO E0431 biotinylated antirabbit, 1:300) was incubated for 1 h at 371C followed by another washing. The samples were then incubated with Streptavidin (1:300; DAKO P 0397) for 1 h at 371C and again washed. The counterstaining was performed with hematoxylin. After placing the samples in an increasing alcohol row, they were embedded. Positive controls used the blood vessels of the small bowel. VEGF concentration was determined by the number of positive cells per blood vessel. Three observers blinded for treatment counted each sample at three different sites for VEGFpositive cells.
Physiologic response
Re-epithelization. Re-epithelization was determined by planimetry and by histological examinations. Planimetry was performed as follows: the wound eschar was left intact for the first 28 days and then removed by Histologically, re-epithelization was determined in skin samples taken 40 days after burn and 5 days after the last injection. Linear skin biopsies were taken and were approximately 4 mm thick in width and extended from the center of the burn wound well into the surrounding normal skin. Skin specimens were fixed overnight at 41C in 4% paraformaldehyde in a HEPESbuffered Hanks solution at pH 7.6. Skin was then stained for HE. 30 The length of re-epithelization was determined by measuring the distance from the normal, uninjured skin (identified by skin appendix structures, such as hair follicle, glands) till the end of the neoepithelium covering the wound and granulation tissue. Measurements were repeated twice by observers blinded to the treatment. Length was calculated by estimating the average of the two measurements.
Epithelial cell layer. HE-stained skin samples were examined to determine the highest neoepidermis. Epithelial cell layers from the basal membrane to the surface were counted by three observers blinded to treatment. The epithelial cell layer was calculated by estimating the average of the three measurements.
Skin cell proliferation and apoptosis. The balance between proliferation and apoptosis is an important indicator for organ homoeostasis, in this case the skin. Skin cell proliferation was determined using antibodies against Ki 67. Ki 67 stains cells that underwent mitosis over the last 24 h. Paraffin sections 3-5 mm thick were mounted on 'Superfrost Plus' slides, heated for 20 min at 721C, deparaffinized and rehydrated. Sections were placed in a microwave for 30 min at 240 W in a citrate buffer at pH ¼ 7.3, then cooled to room temperature. Following antigen retrieval, the slides were rinsed, endogenous peroxidase activity was blocked by using methanolic peroxide, the slides were rinsed again, and primary monoclonal antibody against Ki-67 (BD Phar Mingen, USA, Cat No 36521A) in a dilution of 1:100 was applied. All slides were stained using a Ventana machine and each antibody incubation was performed at 371C and a labeled Streptavidin-biotin-peroxidase method at 371C was used to visualize positive reaction (Ventana Medical Systems basic DAB detection kit, Ventana Medical Systems Inc., USA). A dark brown nuclear precipitate was evaluated as a positive reaction. Crypts of the large bowel were used for positive control and the sections incubated without primary antibody did not yield positive immunoreactivity.
All skin cells in the pannus and along the basal layer were counted. Proliferation was then determined by positive stained skin cells per 100 counted skin cells. Three observers blinded to the treatment groups were recruited to count the cells.
Apoptosis was measured using the terminal deoxyuridine nick end labeling (TUNEL) immunohistochemical method (Apoptag, Oncogene, Baltimore, MD, USA) in order to allow histologic identification to identify apoptotic cells in the skin. Formalin-fixed tissues were processed and embedded into paraffin. Sections of 4-mm, obtained at 40-50 mm intervals, were deparaffinized, rehydrated in graded alcohol and washed in deionized water. Protein was digested using proteinase K (20 ml/ml in PBS) to decrease background contamination. The sections were then incubated with freshly prepared terminal deoxyribonucleotidyl transferase (TdT) enzyme at 371C for 2 h. Following the enzyme incubation, the slides were incubated with anti-digoxigenin peroxidase at room temperature for 30 min. The sections were thoroughly washed and diaminobenzidine-hydrogen peroxidase was applied for color development. Lastly, the sections were counterstained with Mayer's hematoxylin and mounted.
Two sections (4 mm) of each block of tissue were obtained at 40-50 mm intervals. In each section, three observers blinded to treatment counted TUNEL-positive cells. Apoptotic cells were identified as those with a brown staining of the nucleus, or as apoptotic bodies, which are fragments of apoptotic cells engulfed by neighboring epithelial cells. All epithelial cells within the skin were counted and apoptosis was expressed as a percentage of apoptotic cells per 100 epithelial cells. Values for all sections were averaged to calculate apoptosis for the apoptotic rate in the skin.
Cellular net balance, which determines net cell turnover, was calculated by the division of skin cell proliferation divided by skin cell apoptosis.
Collagen morphology and deposition. The quality and quantity of collagen was determined by the Masson Goldner Trichrome staining. 30 Qualitative measurements of the wound collagen were performed by examining the pannus for collagen boundless and the staining intensity of collagen in the area at the wound edge. The collagen morphology and staining intensity were determined by three observers blinded to the treatment. A score from 1 to 4 was given to each sample, whereby 1 ¼ collagen boundless are linear, and 4 ¼ collagen boundless appear to have normal histological structures ('angel curl shape'). Similarly, a score from 1 to 4 was given for staining intensity for the collagen pannus, 1 ¼ weak blue-green staining, few collagen concentration, 4 ¼ strong blue-green staining, high density of collagen in the pannus.
The length of the collagen pannus being deposited in the dermal wound structures was determined by measuring the distance from the normal, uninjured skin till the end of the collagen pannus in the granulation tissue. Measurements were repeated twice by observers blinded to the treatment. Length was calculated by estimating the average of the two measurements. Depth of the collagen pannus was determined in the same manner. The area of the collagen pannus was calculated by multiplying the length times the depth of the pannus.
Neoangiogenesis. Neoangiogenesis was determined
by quantifying blood vessel in the granulation tissue. Three observers blinded to treatment counted the blood vessels in three different sections of the granulation tissue using a magnification of Â 40 (HPF). Values were averaged and calculated as blood vessels per mm 2 .
Ethics and statistics
These studies were reviewed and approved by the Animal Care and Use Committee of the Regierung der Oberpfalz, Bayern, Germany assuring that all animal received humane care according to the criteria outlined in the 'Guide for the Care and Use of Laboratory Animals' published by the National Institutes of Health.
Statistical comparisons were made by analysis of variance (ANOVA) and Student's t-test with the Bonferronis' correction or Student-Newman-Keuls test where appropriate. Data are expressed as means7standard deviation (s.d.) or means7standard error of the mean (s.e.m.). Significance was accepted at Po0.05.
